Next, signaling pathways targeted by the top 20 correlated drugs were analyzed in each cancer, and we found that high PN score patients were more sensitive to drugs targeting the WNT signaling, ERK/MAPK signaling, and PI3K/MTOR signaling pathway (Figure 6(b) A). Here, PIK3CA is linked to cancer.